These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1412156)

  • 1. Inhibition by D-MePhe-Pro-Arg-H (GYKI-14766) of thrombus growth in experimental models of thrombosis.
    Bagdy D; Szabó G; Barabás E; Bajusz S
    Thromb Haemost; 1992 Aug; 68(2):125-9. PubMed ID: 1412156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo anticoagulant and antiplatelet effect of D-Phe-Pro-Arg-H and D-MePhe-Pro-Arg-H.
    Bagdy D; Barabás E; Szabó G; Bajusz S; Széll E
    Thromb Haemost; 1992 Mar; 67(3):357-65. PubMed ID: 1641827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
    Schumacher WA; Steinbacher TE; Heran CL; Seiler SM; Michel IM; Ogletree ML
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1237-42. PubMed ID: 8263785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant and antithrombotic action of the synthetic thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine nitrile.
    Kaiser B; Richter M; Hauptmann J; Markwardt F
    Pharmazie; 1991 Feb; 46(2):128-31. PubMed ID: 1852761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of thrombus formation with glyprolines on various models of prethrombotic state and thrombosis in rats.
    Pastorova VE; Lyapina LA; Ashmarin IP
    Bull Exp Biol Med; 2003 Oct; 136(4):319-22. PubMed ID: 14714071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
    Tohti I; Tursun M; Umar A; Turdi S; Imin H; Moore N
    Thromb Res; 2006; 118(6):733-9. PubMed ID: 16469363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B; Fareed J
    Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
    Jackson CV; Crowe VG; Frank JD; Wilson HC; Coffman WJ; Utterback BG; Jakubowski JA; Smith GF
    J Pharmacol Exp Ther; 1992 May; 261(2):546-52. PubMed ID: 1578372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition of blood coagulation by tripeptide aldehydes--a retrospective screening study focused on the stable D-MePhe-Pro-Arg-H.H2SO4.
    Bagdy D; Barabás E; Bajusz S; Széll E
    Thromb Haemost; 1992 Mar; 67(3):325-30. PubMed ID: 1641823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo characterization of a new synthetic thrombin inhibitor.
    Knabb RM; Kettner CA; Timmermans PB; Reilly TM
    Thromb Haemost; 1992 Jan; 67(1):56-9. PubMed ID: 1615483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp).
    Xiong J; Fang W; Fang W; Bai L; Huo J; Kong Y; Yunman L
    J Pharm Pharmacol; 2009 Jan; 61(1):89-94. PubMed ID: 19126301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist.
    Berry CN; Lorrain J; Lochot S; Delahaye M; Lalé A; Savi P; Lechaire I; Ferrari P; Bernat A; Schaeffer P; Janiak P; Duval N; Grosset A; Herbert JM; O'Connor SE
    Thromb Haemost; 2001 Mar; 85(3):521-8. PubMed ID: 11307825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental studies on the antithrombotic action of a highly effective synthetic thrombin inhibitor.
    Kaiser B; Markwardt F
    Thromb Haemost; 1986 Apr; 55(2):194-6. PubMed ID: 3814237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparin.
    Tapparelli C; Metternich R; Gfeller P; Gafner B; Powling M
    Thromb Haemost; 1995 Apr; 73(4):641-7. PubMed ID: 7495072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
    Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the antithrombotic effects of a synthetic thrombin inhibitor and of heparin in animal models.
    Hauptmann J; Barth A; Schönberger FP; Markwardt F
    Biomed Biochim Acta; 1983; 42(7-8):959-65. PubMed ID: 6651812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.